UB start-up - Cytocybernetics - has developed a new biotechnology tool that could cut the time and money needed for preclinical drug trials in half.

From a UB chemistry lab to a business plan competition, through an R&D pivot to UB Technology Incubator, Dimien is ready with its "smart windows."

Location on UB’s campus, tax relief from New York State taxes, and student brainpower lured back a Western New Yorker looking to grow her software company, Geocove.

Kinex Pharmaceuticals Chief Scientific Officer and co-founder David Hangauer exemplifies how UB is helping grow the 21st century economy in Western New York and around the world.

For-Robin Founding President and UB Professor Kate Rittenhouse-Olson launched her company in 2012 using university technology.